Biomarkers are cellular markers that change upon treatment with a test therapeutic. Quantitative biomarker changes can be correlated with effective drug doses. Such markers are critical for translation of a therapeutic from preclinical studies through to clinical trials.
Cytoscient can perform biomarker discovery for test therapeutics using both proteomic and genomic approaches. Target-relevant models can be set up based on customer needs.
cytoscient.com 